AKERO THERAPEUTICS, INC. - Common Stock (AKRO)

CUSIP: 00973Y108

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
82,872,659
Total 13F shares
10,674,595
Share change
+10,674,595
Total reported value
$204,526,000
Price per share
$19.15
Number of holders
48
Value change
+$204,526,000
Number of buys
48

Quarterly Holders Quick Answers

What is CUSIP 00973Y108?
CUSIP 00973Y108 identifies AKRO - AKERO THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKRO - AKERO THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of AKERO THERAPEUTICS, INC. - Common Stock (AKRO) as of Q2 2019

As of 30 Jun 2019, AKERO THERAPEUTICS, INC. - Common Stock (AKRO) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,674,595 shares. The largest 10 holders included venBio Partners LLC, Redmile Group, LLC, Cormorant Asset Management, LP, JANUS HENDERSON GROUP PLC, BVF INC/IL, HILLHOUSE CAPITAL ADVISORS, LTD., BOXER CAPITAL, LLC, WELLINGTON MANAGEMENT GROUP LLP, HILLHOUSE CAPITAL MANAGEMENT, LTD., and Rock Springs Capital Management LP. This page lists 48 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q4 2025 Across Filers

Q4 2025 holders
2
Q2 2019 holders
48
Holder diff
46
Investor Q4 2025 Shares Q2 2019 Shares Share Diff Share Chg % Q4 2025 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .